Georgia Counseling CE Requirement 10-Hour Package
Included Courses
Courses included in this package. Click on a course to learn more.
- Adolescent Substance Use Disorders for Healthcare Professionals, 2nd edition 1
Course Release: 10/09/2023
About the course
Description of current state: The key risk periods for substance use disorders (SUD) occur during life transitions, such as adolescence. This means that substance use assessment and intervention is especially critical for the adolescent population. The emphasis for this basic-level course is on helping healthcare professionals to effectively assess adolescents for substance use disorders and intervene effectively with adolescents who are dealing with such disorders.
- Protocols on Pain Assessment and Management in Modern Medicine 5
Course release date: 10/9/2023
About the Course
Pain assessment is considered a pivotal aspect of modern medicine. In a broader sense as a concept, pain assessment involves a comprehensive clinical judgment describing and analyzing pain based on the type, significance, and context of the patients’ experience. Describing pain with these assessment tools can be either difficult or easy depending on the demographics of the patients. In pediatric pain assessment, pre-verbal and developmentally disabled children might find it extremely difficult to properly describe the nature and severity of pain. In most cases, modern protocols for pain assessment in this population advise the use of behavioral tools in place of self-reported pain models. Medical personnel handling sessions of pain assessment in the pediatric population are trained to recognize, gauge and document different behavioral cues necessary to improve pain assessment in children. In the geriatric population, pain assessment is more multidimensional, requiring the consideration of different behavioral and physiological cues.
- Psychopharmacology in Behavioral Health Medicine 4
Course release date: 10/09/2023
About the Course
Clinical psychopharmacology has evolved over the past decade. The primary drive for its global adoption in the medical community stems from its unique objective of exploring the physiological influence of medications on the behavior of animals, and by extension humans. In addition, the number of psychopharmacological studies exploring the psychotropic nature of drugs and the possibilities of instituting the findings from these studies in primary care settings has doubled. This has birthed the emergence of a strong link between neurosciences and psychiatry, founded solidly on the biological knowledge of neuronal connectivity, neurotransmitter physiology, drug mechanism of action, neuronal circuitry, and psychotropic drug targets in the brain.